Medicharme has raised debt from BlackRock
July 2019 — Medicharme has raised US$90 million debt from BlackRock to support its ambitious growth plan that involves the acquisition of 500 beds per year, including operating and real estate entities.
Medicharme operates a chain of nursing homes, residential units for disabled elderly people and accommodations for autonomous elderly people. Medicharme focuses on the high-end of the dependency spectrum, including dedicated alzheimer units.
Our role in the transaction
Oaklins' team in France assisted Medicharme on this transaction.
Talk to the deal team
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn more